Protestors turn out at BIO; Ganic Pharma launches; Economic development gets spotlight

> Pfizer and Ranbaxy have come to an agreement that will end most of their five-year battle over the generic production of Lipitor, the world's best-selling drug. Report

> Sanofi-Aventis has made a $2 billion bid for Czech generic drugmaker Zentiva. Report

> No annual BIO meeting would be complete without a protest, and PETA obliged this year turned out in San Diego to raise a hue and cry about the use of animals in drug research. Report

> Massachusetts Governor Deval Patrick showed up with $1 billion in biotech incentives, but he's getting a lot of competition from others in the economic development field. Article

> Biomerieux said it has struck a deal to buy Sweden's AB Biodisk, its fourth acquisition in under two years. Report

> GANIC Pharmaceuticals announced its launch backed by Warburg Pincus. Release

At least eight women have died from shock complications of an acute Clostridial infection following a medical abortion using a combination of mifepristone (Mifeprex) and misoprostol (Cytotec). Report

> While Johnson & Johnson and the Red Cross companies apparently thought it worthwhile to expend significant time and energy fighting over their common red cross emblems, they've now decided to call it quits. J&J has officially released all claims against the Red Cross. Report

And Finally...Regular coffee drinking (up to 6 cups per day) is not associated with increased deaths in either men or women. And both caffeinated and decaffeinated coffee consumption is associated with a somewhat smaller rate of death from heart disease. Release

Suggested Articles

MyoKardia wasn’t looking for a buyout when it started discussing potential partnerships with Bristol Myers Squibb last year.

The patient was hospitalized with febrile neutropenia in the weeks after receiving the drug and died 52 days post-treatment with the CAR-T therapy.

The trial has been paused since early September while FDA reviews the safety of the vaccine in light of a reported case of an inflammatory disorder.